Edit Drescher
Impact in
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 26
- Rheumatoid Arthritis Research and Therapies 22
- Spondyloarthritis Studies and Treatments 7
- Systemic Lupus Erythematosus Research 6
- Hematology 10
- Autoimmune and Inflammatory Disorders Research 10
- Co-authors
- Désirée van der Heijde (5 shared papers)Terence Rooney (6 shared papers)Scott D. Beattie (6 shared papers)Douglas Schlichting (3 shared papers)Paul Emery (8 shared papers)Maria Greenwald (7 shared papers)Thijs Hendrikx (2 shared papers)Dona Fleishaker (2 shared papers)
- Journals
- Annals of the Rheumatic Diseases (13 papers)Arthritis & Rheumatology (4 papers)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (3 papers)Rheumatology and Therapy (2 papers)RMD Open (2 papers)
- Partner nations
- United StatesHungaryUnited Kingdom
In The Last Decade
Edit Drescher
34 papers receiving 1.3k citations
Edit Drescher's Hit Papers
Peers
Comparison fields: 5 of 77
- Rheumatology 922
- Hematology 463
- Immunology 486
- Genetics 211
- Oncology 301
Countries citing papers authored by Edit Drescher
This map shows the geographic impact of Edit Drescher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edit Drescher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edit Drescher more than expected).
Fields of papers citing papers by Edit Drescher
This network shows the impact of papers produced by Edit Drescher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edit Drescher. The network helps show where Edit Drescher may publish in the future.
Co-authors
The 25 scholars most cited alongside Edit Drescher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study Hit paper breakdown → | 2016 | 301 |
| 2 | Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study Hit paper breakdown → | 2017 | 272 |
| 3 | 2014 | 225 | |
| 4 | 2016 | 122 | |
| 5 | 2015 | 83 | |
| 6 | 2012 | 76 | |
| 7 | A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis Hit paper breakdown → | 2023 | 74 |
| 8 | 2015 | 24 | |
| 9 | 1963 | 21 | |
| 10 | 2018 | 17 | |
| 11 | 2019 | 15 | |
| 12 | 2021 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 24-Week Results of a Blinded Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Januse Kinase 2 Inhibitor, in Combination with Traditional Disease Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis. | 2012 | 10 |
| 15 | 2022 | 10 | |
| 16 | [CT diagnosis of malalignment following distal radius fracture]. | 1989 | 9 |
| 17 | 2022 | 8 | |
| 18 | 2014 | 5 | |
| 19 | Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomized, Placebo-Controlled, Dose-Ranging Study | 2015 | 3 |
| 20 | 1989 | 3 |
About Edit Drescher
Edit Drescher is a scholar working on Rheumatology, Hematology, Immunology, Genetics and Surgery, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (22 papers), Autoimmune and Inflammatory Disorders Research (10 papers), Spondyloarthritis Studies and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Systemic Lupus Erythematosus Research (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). The work is most often cited by research in Rheumatology (922 citations), Hematology (463 citations), Immunology (486 citations), Genetics (211 citations) and Oncology (301 citations). Edit Drescher has collaborated with scholars based in United States, Hungary and United Kingdom. Frequent co-authors include Désirée van der Heijde, Terence Rooney, Scott D. Beattie, Douglas Schlichting, Paul Emery, Maria Greenwald, Thijs Hendrikx, Dona Fleishaker, James Cheng‐Chung Wei and Atul Deodhar. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Rheumatology and Therapy and RMD Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.